Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ernest Mario

Affiliations

  • Director at Eyenovia Inc. (EYEN), 2019-07-15
  • at Celgene Corp (CELG), 2019-06-17
  • Director at Soleno Therapeutics Inc (SLNO), 2019-06-12
  • Director at Kindred Biosciences Inc. (KIN), 2019-02-05
  • Director at Tonix Pharmaceuticals Holding Corp. (TNXP), 2018-06-27
  • Director at Chimerix Inc (CMRX), 2018-05-21
  • Director at Boston Scientific Corp (BSX), 2015-11-17
  • Director at Xenoport Inc (XNPT), 2015-05-21
  • Director at Vivus Inc (VVUS), 2013-05-30
  • Director at Maxygen Inc (MAXY), 2012-06-07
  • Director at Pharmaceutical Product Development Inc (PPDI), 2011-12-06
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EYEN $2.78 35,971 Director 272,741 2019-07-11 Filing
EYEN $10.00 90,000 Director 236,770 2018-01-29 Filing
TNXP $4.48 16,500 Director 50,000 2018-06-25 Filing
TNXP $0.41 120,000 Director 120,000 2016-11-23 Filing
TNXP $0.00 100,000 Director 630,724 2016-10-31 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CELG $92.32 12,000 44,413 2018-08-09 Filing
CMRX $4.81 15,000 Director 108,167 2018-05-18 Filing
CMRX $4.80 30,000 Director 123,167 2018-05-17 Filing
CMRX $4.79 30,000 Director 153,167 2018-05-16 Filing
CMRX $4.69 30,000 Director 183,167 2018-05-15 Filing